Comparison of real-life data from patients with NGS panel negative and <i>KRAS</i> mutation positive metastatic lung adenocarcinoma.

Gökyer, Ali; Küçükarda, Ahmet; Köstek, Osman; Gökmen, Ivo; Özcan, Erkan; Sayin, Sezin; Tastekin, Ebru; Hacioglu, Bekir; Erdogan, Bülent; Uzunoglu, Sernaz; Çiçin, Irfan

Comparison of real-life data from patients with NGS panel negative and KRAS mutation positive metastatic lung adenocarcinoma.

Gökyer, Ali; Küçükarda, Ahmet; Köstek, Osman; Gökmen, Ivo; Özcan, Erkan; Sayin, Sezin; Tastekin, Ebru; Hacioglu, Bekir; Erdogan, Bülent; Uzunoglu, Sernaz; Çiçin, Irfan.

Afiliación

Gökyer A; Department of Internal Medicine, Division of Medical Oncology, Trakya University School of Medicine, Edirne, Turkey.
Küçükarda A; Department of Internal Medicine, Division of Medical Oncology, Trakya University School of Medicine, Edirne, Turkey.
Köstek O; Department of Internal Medicine, Division of Medical Oncology, Trakya University School of Medicine, Edirne, Turkey.
Gökmen I; Department of Internal Medicine, Division of Medical Oncology, Trakya University School of Medicine, Edirne, Turkey.
Özcan E; Department of Internal Medicine, Division of Medical Oncology, Trakya University School of Medicine, Edirne, Turkey.
Sayin S; Trakya University School of Medicine, Edirne, Turkey.
Tastekin E; Department of Pathology, Trakya University School of Medicine, Edirne, Turkey.
Hacioglu B; Department of Internal Medicine, Division of Medical Oncology, Trakya University School of Medicine, Edirne, Turkey.
Erdogan B; Department of Internal Medicine, Division of Medical Oncology, Trakya University School of Medicine, Edirne, Turkey.
Uzunoglu S; Department of Internal Medicine, Division of Medical Oncology, Trakya University School of Medicine, Edirne, Turkey.
Çiçin I; Department of Internal Medicine, Division of Medical Oncology, Trakya University School of Medicine, Edirne, Turkey.

Tumori ; 108(2): 141-146, 2022 Apr.

Article en En | MEDLINE | ID: mdl-33624577

Asunto(s)

Adenocarcinoma del Pulmón; Carcinoma de Pulmón de Células no Pequeñas; Neoplasias Pulmonares; Adenocarcinoma del Pulmón/tratamiento farmacológico; Adenocarcinoma del Pulmón/genética; Adenocarcinoma del Pulmón/patología; Carcinoma de Pulmón de Células no Pequeñas/tratamiento farmacológico; Carcinoma de Pulmón de Células no Pequeñas/genética; Carcinoma de Pulmón de Células no Pequeñas/patología; Secuenciación de Nucleótidos de Alto Rendimiento/métodos; Humanos; Neoplasias Pulmonares/tratamiento farmacológico; Neoplasias Pulmonares/genética; Neoplasias Pulmonares/patología; Mutación; Pronóstico; Proteínas Proto-Oncogénicas p21(ras)/genética; Estudios Retrospectivos

Palabras clave

KRAS mutation; KRASG12C mutation; Lung adenocarcinoma; next-generation sequencing

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Carcinoma de Pulmón de Células no Pequeñas / Adenocarcinoma del Pulmón / Neoplasias Pulmonares Tipo de estudio: Observational_studies / Prognostic_studies Límite: Humans Idioma: En Revista: Tumori Año: 2022 Tipo del documento: Article País de afiliación: Turquía

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google